Girish Venkataraman, MD

Assistant Professor
Medical Director, Immunohistochemistry

Department of Pathology
The University of Chicago
5841 S. Maryland Ave.
MC 0008, Room TW-055B
Chicago, IL 60637
Office: (773) 702-5273
Fax: (773) 702-1200

Clinical Interests

Dr. Venkataraman oversees the immunohistochemistry lab located in the Clinical Hematology laboratory. He is part of the hematopathology team which handles the routine bone marrow biopsies/aspirates, lymph node biopsies, and other heme-related material, and on the Clinical Hematology Lab service dealing with body fluid/CSF analysis.

Research Interests

Dr. Venkataraman's main area of interest is in the identification of prognostic biomarkers in classical Hodgkin lymphoma (cHL). He recently demonstrated that aberrant T-cell antigen expression in classical Hodgkin lymphoma is associated with worse outcome. Another recent work demonstrating the expression of CD15- an antigen traditionally restricted to cHLs- in cases of Nodular lymphocyte predominant Hodgkin lymphoma (NLPHL) underscores the existence of grey zones between these two otherwise clinically and histologically distinct subtypes of Hodgkin lymphoma.

select Publications

  1.  Nicolae A, Pittaluga S, Venkataraman G, and Jaffe ES et al. Peripheral T-cell lymphomas of follicular T-helper cell derivation with Hodgkin/Reed-Sternberg cells of B-cell lineage: both EBV-positive and EBV-negative variants exist. Am J Surg Pathol. 2013 Jun;37(6):816-26
  2. Venkataraman G, Song JY, Pittaluga S, and Jaffe ES et al. Aberrant T-cell antigen expression in classical Hodgkin lymphoma is associated with decreased event-free survival and overall survival. Blood. 2013 Mar 7;121(10):1795-804.
  3. Venkataraman G, Raffeld M, Pittaluga S, Jaffe ES. CD15-expressing nodular lymphocyte-predominant Hodgkin lymphoma. Histopathology. 2011 Apr;58(5):803-5.
  4. Dojcinov SD, Venkataraman G, Pittaluga S, Wlodarska I, Schrager JA, Raffeld M,Hills RK, Jaffe ES. Age-related EBV-associated lymphoproliferative disorders in the Western population: a spectrum of reactive lymphoid hyperplasia and lymphoma. Blood. 2011 May 5;117(18):4726-35.

PubMed Link to Dr. Girish Venkataraman publications